Prognosis of Taiwanese patients with isolated optic neuritis after intravaneous methylprednisolone pulse therapy

Journal of the Formosan Medical Association

Volumn 106, Issue 8, 2007, Pages 656-663

  Chang, Yo Chen ^a,b   Wu, Wen Chuan ^b   Tsai, Rong Kung ^c  

^a KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c TZU CHI UNIVERSITY   (Taiwan)

Author keywords

Multiple sclerosis; Optic neuritis; Papillitis; Retrobulbar neuritis

Indexed keywords

METHYLPREDNISOLONE SODIUM SUCCINATE; PREDNISOLONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG PULSE THERAPY; FEMALE; HUMAN; INCIDENCE; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NEURITIS; PAPILLITIS; PROGNOSIS; RECURRENCE RISK; RETROBULBAR OPTIC NEUROPATHY; RETROSPECTIVE STUDY; TAIWAN; VISUAL ACUITY;

EID: 34548511829     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-6646(08)60023-6     Document Type: Article

References (26)

1. Eber GC. Optic neuritis and multiple sclerosis. Arch Neurol 1985;42:702-4.
2. Rolak LA, Beck RW, Paty DW, et al; Optic Neuritis Study Group. Cerebrospinal fluid in acute optic neuritis: experience of the optic neuritis treatment trial. Neurology 1996;46: 368-72.
3. Jin YP, de Pedro-Cuesta J, Soderstrom M, et al. Incidence of optic neuritis in Stockholm, Sweden 1990-1995, I: age, sex, birth and ethnic-group related patterns. J Neurol Sci 1998;159:107-14.
4. Beck RW, Cleary PA, Anderson MM Jr, et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. N Engl J Med 1992;326:581-8.
5. Optic Neuritis Study Group. The clinical profile of optic neuritis: experience of the optic neuritis treatment trial. Arch Ophthalmol 1991;109:1673-8.
6. Jin YP, de Pedro-Cuesta J, Soderstrom M, et al. Incidence of optic neuritis in Stockholm, Sweden 1990-1995, II: time and space patterns. Arch Neurol 1999;56:975-80.
7. Barlow JS. Multiple sclerosis in North Korea and China. Neurology 1967;17:802.
8. Wang JC, Tow S, Aung T, et al. The presentation, aetiology, management and outcome of optic neuritis in an Asian population. Clin Exp Ophthalmol 2001;29:312-5.
9. Beck RW, Trobe JD. What we have learned from the optic neuritis treatment trial. Ophthalmology 1995;102:1504-8.
10. Optic Neuritis Study Group. The optic neuritis treatment trial: three-year follow-up results. Arch Ophthalmol 1995; 113:136-7.
11. Bee YS, Lin MC, Wang CC, et al. Optic neuritis: clinical analysis of 27 cases. Kaohsiung J Med Sci 2003;19: 105-11.
12. Lin YC, Yen MY, Hsu WM, et al. Low conversion rate to multiple sclerosis in idiopathic optic neuritis patients in Taiwan. Jpn J Ophthalmol 2006;50:170-5.
13. Keltner JL, Johnson CA, Spurr JO, et al. Baseline visual field profile of optic neuritis. The experience of the optic neuritis treatment trial. Arch Ophthalmol 1993;111: 231-4.
14. Poser CM, Paty DW, Scheiberg L. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-31.
15. Wakakura M, Minei-Higa R, Oono S, et al. Baseline features of idiopathic optic neuritis as determined by a multicenter treatment trial in Japan. Jpn J Ophthalmol 1999;43:127-32.
16. Kanski JJ. Neuro-ophthalmology. In: Kanski JJ, ed. Clinical Ophthalmology, 4th edition. Oxford: Butterworth-Heinemann, 1999:590-2.
17. Optic Neuritis Study Group. The 5-year risk of MS after optic neuritis. Neurol 1997;49:1404-12.
18. Optic Neuritis Study Group. High and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis. Arch Ophthalmol 2003;121:944-9.
19. Kahana E, Alter M, Feldman S. Optic neuritis in relation to multiple sclerosis. J Neurol 1976;213:87-95.
20. Miller NR, Newman NJ. Multiple sclerosis and related demyelinating disease. In: Newman NJ, ed. Clinical Neuro-Ophthalmology, 5th edition. Pennsylvania: Williams & Wilkins, 1997:5539-76.
21. Francis DA, Compston DAS, Batchelor J R, et al. A reassessment of the risk of multiple sclerosis developing in patients with optic neuritis after extended follow-up. J Neurol Neurosurg Psychiatry 1987;50:758-65.
22. Sandberg-Wollheim M, Rynke H, Cronqvist S, et al. A long-term prospective study of optic neuritis: evaluation of risk factors. Ann Neurol 1990;27:386-93.
23. Rodriquez M, Siva A, Cross SA, et al. Optic neuritis: a population-based study in Olmsted County, Minnesota. Neurology 1995;45:244-50.
24. Fritch JA, McLeod JG, Hely M. Acute optic neuritis in Australia: a 13 year prospective study. J Neurol Neurosurg Psychiatry 2000;68:246-51.
25. Sergott RC, Brown MJ. Current concepts of the pathogenesis of optic neuritis associated with multiple sclerosis. Suru Ophthalmol 1988;33:108-16.
26. Shibasaki H, Okihiro MM, Kuroiwa Y. Multiple sclerosis among Orientals and Caucasians in Hawaii: a reappraisal. Neurology 1978;28:113-8.